CPI-0209 is an investigational medication being studied for its potential to treat advanced solid tumors and lymphomas. In this clinical trial, researchers are working to determine the highest dose of CPI-0209 that patients can tolerate without severe side effects. They are also evaluating how effective CPI-0209 is in reducing or controlling the growth of these tumors. The study is divided into two phases: the first phase focuses on finding the right dose, while the second phase assesses the medication’s ability to fight cancer.

Urothelial Carcinoma – This is a type of cancer that occurs in the urinary system, primarily affecting the bladder. It begins in the urothelial cells that line the inside of the bladder and can spread to nearby tissues and organs. As it progresses, it may invade deeper layers of the bladder wall and potentially metastasize to other parts of the body.

Ovarian Clear Cell Cancer – This is a rare form of ovarian cancer characterized by the presence of clear cells in the tumor. It typically presents as a solid mass in the ovaries and can be aggressive, often diagnosed at an advanced stage. The cancer may spread to other parts of the body, including the abdominal cavity and lymph nodes.

Endometrial Carcinoma – This cancer originates in the lining of the uterus, known as the endometrium. It often presents with abnormal uterine bleeding and can invade the uterine wall and spread to other pelvic organs. If not detected early, it may metastasize to distant sites such as the lungs or liver.

Peripheral T-cell Lymphoma – This is a group of aggressive lymphomas that originate from mature T-cells. It can present with symptoms such as swollen lymph nodes, fever, and weight loss. The disease can spread rapidly to other lymph nodes and organs, including the liver and bone marrow.

Germinal Center B-cell Diffuse Large B-cell Lymphoma (GCB-DLBCL) – This is a subtype of non-Hodgkin lymphoma that arises from B-cells in the germinal center of lymph nodes. It is characterized by rapidly growing tumors that can occur in various parts of the body. The disease can spread to other lymph nodes and organs, leading to systemic symptoms.

Malignant Pleural Mesothelioma – This is a rare cancer that develops in the lining of the lungs, known as the pleura. It is often associated with asbestos exposure and can cause symptoms such as chest pain and shortness of breath. The cancer can invade nearby tissues and organs, and may spread to distant sites.

Malignant Peritoneal Mesothelioma – This cancer occurs in the lining of the abdominal cavity, called the peritoneum. It is also linked to asbestos exposure and can present with abdominal pain and swelling. The disease can spread to other abdominal organs and tissues, leading to complications.

Metastatic Castration-Resistant Prostate Cancer (mCRPC) – This is an advanced form of prostate cancer that continues to progress despite hormone therapy. It can spread to bones, lymph nodes, and other organs, causing symptoms such as bone pain and urinary issues. The cancer is characterized by its resistance to conventional hormonal treatments.